Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551K Sell
4,288
-97
-2% -$11.4K 0.25% 101
2026
Q1
$527K Buy
4,385
+4
+0.1% +$462 0.27% 91
2025
Q4
$461K Buy
4,381
+679
+18% +$63.7K 0.24% 101
2025
Q3
$311K Sell
3,702
-120
-3% -$9.88K 0.17% 120
2025
Q2
$303K Sell
3,822
-657
-15% -$52.2K 0.17% 117
2025
Q1
$402K Buy
4,479
+6
+0.1% +$560 0.24% 100
2024
Q4
$445K Buy
4,473
+715
+19% +$73.7K 0.26% 93
2024
Q3
$427K Buy
+3,758
New +$446K 0.26% 92

Other funds holding MRK

Tudor Financial's MRK Position: Q2 2026 in Review

Tudor Financial reduced its Merck (MRK) stake by 2.2% in Q2 2026, selling an estimated $11.4K and leaving 4,288 shares worth $551K. The position accounts for 0.25% of the portfolio, ranked #101.

Tudor Financial first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tudor Financial held 4,288 shares of Merck worth $551K as of Q2 2026.
  • Tudor Financial sold 97 Merck shares in Q2 2026, an estimated $11.4K.
  • Merck made up 0.25% of Tudor Financial's portfolio in Q2 2026, its #101 holding.
  • Tudor Financial first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tudor Financial's 13F filing for Q2 2026, filed 6 Aug 2026.